EUVIMEDEUVIMED entdecken
EditorialOpen Access

Metabolic Dysfunction-associated Steatotic Liver Disease and Type 2 Diabetes: A Deadly Synergy

Damien Leith, Yeun Yi Lin, Paul Brennan

touchREVIEWS in Endocrinology · 31.10.2024 · 20 (2)

DOI: 10.17925/ee.2024.20.2.2 ↗

Kurz gefasst

Editorial in der Zeitschrift touchREVIEWS in Endocrinology, online erschienen am 31.10.2024. Verfasst von Damien Leith und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Centre, Ninewells Hospital, Dundee, UK. Die Arbeit wurde bisher 47-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD) are both facets of the metabolic syndrome, associated with obesity and insulin resistance. MASLD, a term that replaces non-alcoholic fatty liver disease (NAFLD), occurs in up to 70% of people with T2D. Not only do T2D and MASLD commonly co-occur, but there is a synergistic, bidirectional relationship between these conditions, meaning that each affects the natural disease course of the other. As such, it is important for those caring for people with T2D to recognize the importance of this co-diagnosis. In this summary, we detail the synergistic relationship between T2D and MASLD, explain the current challenges in recognizing this common co-diagnosis and suggest practical approaches for those caring for people with T2D to improve the diagnosis and treatment of MASLD.

Schlagwörter

Stichwörter der Autor:innen

Alcohol-related liver diseasecardiometabolic risk factorsliver cirrhosismetabolic and alcoholic-related steatotic liver diseasemetabolic dysfunction-associated steatohepatitismetabolic dysfunction-associated steatotic liver diseasenon-alcoholic fatty liver diseasenon-alcoholic steatohepatitissteatotic liver diseasetype 2 diabetes

Autor:innen und Institutionen

  • Clinical Research Centre, Ninewells Hospital, Dundee, UK.

Zitieren

APA

Leith, D., Lin, Y. Y., & Brennan, P. (2024). Metabolic Dysfunction-associated Steatotic Liver Disease and Type 2 Diabetes: A Deadly Synergy. touchREVIEWS in Endocrinology, 20(2). https://doi.org/10.17925/ee.2024.20.2.2

Vancouver

Leith D, Lin YY, Brennan P. Metabolic Dysfunction-associated Steatotic Liver Disease and Type 2 Diabetes: A Deadly Synergy. touchREVIEWS in Endocrinology. 2024;20(2). doi:10.17925/ee.2024.20.2.2

BibTeX
@article{Leith2024,
  author = {Leith, Damien and Lin, Yeun Yi and Brennan, Paul},
  title = {Metabolic Dysfunction-associated Steatotic Liver Disease and Type 2 Diabetes: A Deadly Synergy},
  journal = {touchREVIEWS in Endocrinology},
  year = {2024},
  volume = {20},
  number = {2},
  doi = {10.17925/ee.2024.20.2.2}
}
Kostenlos starten →